The biology of Ku and its potential oncogenic role in cancer

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1765, Issue 2, 2006, Pages 223-234

  Gullo, Charles ^a,b   Au, Melvin ^a,c   Feng, Ge ^a   Teoh, Gerrard ^a,c  

^a Singapore Health Services   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

^c SGH   (Singapore)

Author keywords

Apoptosis; Carcinogenesis; DNA repair; Genomic instability

Indexed keywords

ADENOSINE TRIPHOSPHATASE; BLEOMYCIN; HELICASE; KU ANTIGEN; MITOMYCIN C; PROTEIN KINASE; PROTEIN SUBUNIT;

APOPTOSIS; AUTOIMMUNE DISEASE; CANCER; CANCER RADIOTHERAPY; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL PROLIFERATION; CELL SURVIVAL; CHROMOSOME ABERRATION; DIMERIZATION; DNA REPAIR; DNA STRAND BREAKAGE; GAMMA RADIATION; GENE EXPRESSION; GENETIC DISORDER; GENETIC TRANSCRIPTION; GENOMIC INSTABILITY; HUMAN; MUTATIONAL ANALYSIS; NONHUMAN; NONSENSE MUTATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN VARIANT; REVIEW; RISK ASSESSMENT; TELOMERE; TRANSCRIPTION REGULATION;

ANIMALS; ANTIGENS, NUCLEAR; CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; HUMANS; NEOPLASMS;

EID: 33646160992     PISSN: 0304419X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbcan.2006.01.001     Document Type: Review

References (101)

1. Mimori T., Akizuki M., Yamagata H., Inada S., Yoshida S., and Homma M. Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis-scleroderma overlap. J. Clin. Invest. 68 (1981) 611-620
2. Tuteja R., and Tuteja N. Ku autoantigen: a multifunctional DNA-binding protein. Crit. Rev. Biochem. Mol. Biol. 35 (2000) 1-33
3. Walker J.R., Corpina R.A., and Goldberg J. Structure of the Ku heterodimer bound to DNA and its implications for double-strand break repair. Nature 412 (2001) 607-614
4. Cary R.B., Peterson S.R., Wang J., Bear D.G., Bradbury E.M., and Chen D.J. DNA looping by Ku and the DNA-dependent protein kinase. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 4267-4272
5. Nick McElhinny S.A., Snowden C.M., McCarville J., and Ramsden D.A. Ku recruits the XRCC4-ligase IV complex to DNA ends. Mol. Cell. Biol. 20 (2000) 2996-3003
6. Wu X., and Lieber M.R. Protein-protein and protein-DNA interaction regions within the DNA end-binding protein Ku70-Ku86. Mol. Cell. Biol. 16 (1996) 5186-5193
7. Myung K., He D.M., Lee S.E., and Hendrickson E.A. KARP-1: a novel leucine zipper protein expressed from the Ku86 autoantigen locus is implicated in the control of DNA-dependent protein kinase activity. EMBO J. 16 (1997) 3172-3184
8. Koike M., Awaji T., Kataoka M., Tsujimoto G., Kartasova T., Koike A., and Shiomi T. Differential subcellular localization of DNA-dependent protein kinase components Ku and DNA-PKcs during mitosis. J. Cell Sci. 112 Pt. 22 (1999) 4031-4039
9. Jin S., and Weaver D.T. Double-strand break repair by Ku70 requires heterodimerization with Ku80 and DNA binding functions. EMBO J. 16 (1997) 6874-6885
10. Gu Y., Seidl K.J., Rathbun G.A., Zhu C., Manis J.P., van der S.N., Davidson L., Cheng H.L., Sekiguchi J.M., Frank K., Stanhope-Baker P., Schlissel M.S., Roth D.B., and Alt F.W. Growth retardation and leaky SCID phenotype of Ku70-deficient mice. Immunity 7 (1997) 653-665
11. Singleton B.K., Priestley A., Steingrimsdottir H., Gell D., Blunt T., Jackson S.P., Lehmann A.R., and Jeggo P.A. Molecular and biochemical characterization of xrs mutants defective in Ku80. Mol. Cell. Biol. 17 (1997) 1264-1273
12. Errami A., Smider V., Rathmell W.K., He D.M., Hendrickson E.A., Zdzienicka M.Z., and Chu G. Ku86 defines the genetic defect and restores X-ray resistance and V(D)J recombination to complementation group 5 hamster cell mutants. Mol. Cell. Biol. 16 (1996) 1519-1526
13. Taccioli G.E., Gottlieb T.M., Blunt T., Priestley A., Demengeot J., Mizuta R., Lehmann A.R., Alt F.W., Jackson S.P., and Jeggo P.A. Ku80: product of the XRCC5 gene and its role in DNA repair and V(D)J recombination. Science 265 (1994) 1442-1445
14. Ochem A.E., Skopac D., Costa M., Rabilloud T., Vuillard L., Simoncsits A., Giacca M., and Falaschi A. Functional properties of the separate subunits of human DNA helicase II/Ku autoantigen. J. Biol. Chem. 272 (1997) 29919-29926
15. Higashiura M., Shimizu Y., Tanimoto M., Morita T., and Yagura T. Immunolocalization of Ku-proteins (p80/p70): localization of p70 to nucleoli and periphery of both interphase nuclei and metaphase chromosomes. Exp. Cell Res. 201 (1992) 444-451
16. Yaneva M., and Jhiang S. Expression of the Ku protein during cell proliferation. Biochim. Biophys. Acta 1090 (1991) 181-187
17. Yu E., Song K., Moon H., Maul G.G., and Lee I. Characteristic immunolocalization of Ku protein as nuclear matrix. Hybridoma 17 (1998) 413-420
18. Koike M., Ikuta T., Miyasaka T., and Shiomi T. Ku80 can translocate to the nucleus independent of the translocation of Ku70 using its own nuclear localization signal. Oncogene 18 (1999) 7495-7505
19. Bakalkin G., Yakovleva T., Hurd Y.L., Nussenzweig A., Li G.C., and Terenius L. Autoantigen Ku in the brain. Developmentally regulated expression and subcellular localization. NeuroReport 9 (1998) 2147-2151
20. Dalziel R.G., Mendelson S.C., and Quinn J.P. The nuclear autoimmune antigen Ku is also present on the cell surface. Autoimmunity 13 (1992) 265-267
21. Prabhakar B.S., Allaway G.P., Srinivasappa J., and Notkins A.L. Cell surface expression of the 70-kD component of Ku, a DNA-binding nuclear autoantigen. J. Clin. Invest. 86 (1990) 1301-1305
22. Teoh G., Urashima M., Greenfield E.A., Nguyen K.A., Lee J.F., Chauhan D., Ogata A., Treon S.P., and Anderson K.C. The 86-kD subunit of Ku autoantigen mediates homotypic and heterotypic adhesion of multiple myeloma cells. J. Clin. Invest. 101 (1998) 1379-1388
23. Klein B., and Bataille R. Cytokine network in human multiple myeloma. Hematol./Oncol. Clin. North Am. 6 (1992) 273-284
24. Tovari J., Szende B., Bocsi J., Falaschi A., Simoncsits A., Pongor S., Erchegyi J., Stetak A., and Keri G. A somatostatin analogue induces translocation of Ku 86 autoantigen from the cytosol to the nucleus in colon tumour cells. Cell. Signal. 10 (1998) 277-282
25. Fewell J.W., and Kuff E.L. Intracellular redistribution of Ku immunoreactivity in response to cell-cell contact and growth modulating components in the medium. J. Cell Sci. 109 Pt. 7 (1996) 1937-1946
26. Hammarsten O., and Chu G. DNA-dependent protein kinase: DNA binding and activation in the absence of Ku. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 525-530
27. West R.B., Yaneva M., and Lieber M.R. Productive and nonproductive complexes of Ku and DNA-dependent protein kinase at DNA termini. Mol. Cell. Biol. 18 (1998) 5908-5920
28. J.E. Haber, DNA repair. Gatekeepers of recombination, Nature, 398, (1999) 665-667.
29. Smith G.C., and Jackson S.P. The DNA-dependent protein kinase. Genes Dev. 13 (1999) 916-934
30. Jackson S.P., and Jeggo P.A. DNA double-strand break repair and V(D)J recombination: involvement of DNA-PK. Trends Biochem. Sci. 20 (1995) 412-415
31. Anderson C.W. DNA damage and the DNA-activated protein kinase. Trends Biochem. Sci. 18 (1993) 433-437
32. Lees-Miller S.P. The DNA-dependent protein kinase, DNA-PK: 10 years and no ends in sight. Biochem. Cell. Biol. 74 (1996) 503-512
33. Critchlow S.E., Bowater R.P., and Jackson S.P. Mammalian DNA double-strand break repair protein XRCC4 interacts with DNA ligase IV. Curr. Biol. 7 (1997) 588-598
34. Leber R., Wise T.W., Mizuta R., and Meek K. The XRCC4 gene product is a target for and interacts with the DNA-dependent protein kinase. J. Biol. Chem. 273 (1998) 1794-1801
35. Reliene R., Bishop A.J., Li G., and Schiestl R.H. Ku86 deficiency leads to reduced intrachromosomal homologous recombination in vivo in mice. DNA Repair (Amst.) 3 (2004) 103-111
36. Blunt T., Finnie N.J., Taccioli G.E., Smith G.C., Demengeot J., Gottlieb T.M., Mizuta R., Varghese A.J., Alt F.W., and Jeggo P.A. Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation. Cell 80 (1995) 813-823
37. Blunt T., Gell D., Fox M., Taccioli G.E., Lehmann A.R., Jackson S.P., and Jeggo P.A. Identification of a nonsense mutation in the carboxyl-terminal region of DNA-dependent protein kinase catalytic subunit in the scid mouse. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 10285-10290
38. Feldmann E., Schmiemann V., Goedecke W., Reichenberger S., and Pfeiffer P. DNA double-strand break repair in cell-free extracts from Ku80-deficient cells: implications for Ku serving as an alignment factor in non-homologous DNA end joining. Nucleic Acids Res. 28 (2000) 2585-2596
39. Bianchi A., and de Lange T. Ku binds telomeric DNA in vitro. J. Biol. Chem. 274 (1999) 21223-21227
40. Hsu H.L., Gilley D., Blackburn E.H., and Chen D.J. Ku is associated with the telomere in mammals. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 12454-12458
41. Bailey S.M., Meyne J., Chen D.J., Kurimasa A., Li G.C., Lehnert B.E., and Goodwin E.H. DNA double-strand break repair proteins are required to cap the ends of mammalian chromosomes. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 14899-14904
42. Samper E., Goytisolo F.A., Slijepcevic P., van Buul P.P., and Blasco M.A. Mammalian Ku86 protein prevents telomeric fusions independently of the length of TTAGGG repeats and the G-strand overhang. EMBO Rep. 1 (2000) 244-252
43. Chai W., Ford L.P., Lenertz L., Wright W.E., and Shay J.W. Human Ku70/80 associates physically with telomerase through interaction with hTERT. J. Biol. Chem. 277 (2002) 47242-47247
44. Hsu H.L., Gilley D., Galande S.A., Hande M.P., Allen B., Kim S.H., Li G.C., Campisi J., Kohwi-Shigematsu T., and Chen D.J. Ku acts in a unique way at the mammalian telomere to prevent end joining. Genes Dev. 14 (2000) 2807-2812
45. Goytisolo F.A., Samper E., Edmonson S., Taccioli G.E., and Blasco M.A. The absence of the dna-dependent protein kinase catalytic subunit in mice results in anaphase bridges and in increased telomeric fusions with normal telomere length and G-strand overhang. Mol. Cell. Biol. 21 (2001) 3642-3651
46. Polotnianka R.M., Li J., and Lustig A.J. The yeast Ku heterodimer is essential for protection of the telomere against nucleolytic and recombinational activities. Curr. Biol. 8 (1998) 831-834
47. d'Adda d.f., Hande M.P., Tong W.M., Roth D., Lansdorp P.M., Wang Z.Q., and Jackson S.P. Effects of DNA nonhomologous end-joining factors on telomere length and chromosomal stability in mammalian cells. Curr. Biol. 11 (2001) 1192-1196
48. Espejel S., Franco S., Rodriguez-Perales S., Bouffler S.D., Cigudosa J.C., and Blasco M.A. Mammalian Ku86 mediates chromosomal fusions and apoptosis caused by critically short telomeres. EMBO J. 21 (2002) 2207-2219
49. Sawada M., Sun W., Hayes P., Leskov K., Boothman D.A., and Matsuyama S. Ku70 suppresses the apoptotic translocation of Bax to mitochondria. Nat. Cell Biol. 5 (2003) 320-329
50. Li G.C., Ouyang H., Li X., Nagasawa H., Little J.B., Chen D.J., Ling C.C., Fuks Z., and Cordon-Cardo C. Ku70: a candidate tumor suppressor gene for murine T cell lymphoma. Mol. Cell 2 (1998) 1-8
51. Giffin W., Torrance H., Rodda D.J., Prefontaine G.G., Pope L., and Hache R.J. Sequence-specific DNA binding by Ku autoantigen and its effects on transcription. Nature 380 (1996) 265-268
52. Liu E.S., and Lee A.S. Common sets of nuclear factors binding to the conserved promoter sequence motif of two coordinately regulated ER protein genes, GRP78 and GRP94. Nucleic Acids Res. 19 (1991) 5425-5431
53. Li G.C., Yang S.H., Kim D., Nussenzweig A., Ouyang H., Wei J., Burgman P., and Li L. Suppression of heat-induced hsp70 expression by the 70-kDa subunit of the human Ku autoantigen. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 4512-4516
54. Aravind L., and Koonin E.V. Prokaryotic homologs of the eukaryotic DNA-end-binding protein Ku, novel domains in the Ku protein and prediction of a prokaryotic double-strand break repair system. Genome Res. 11 (2001) 1365-1374
55. Mo X., and Dynan W.S. Subnuclear localization of Ku protein: functional association with RNA polymerase II elongation sites. Mol. Cell. Biol. 22 (2002) 8088-8099
56. Woodard R.L., Lee K.J., Huang J., and Dynan W.S. Distinct roles for Ku protein in transcriptional reinitiation and DNA repair. J. Biol. Chem. 276 (2001) 15423-15433
57. Tuteja N., Tuteja R., Ochem A., Taneja P., Huang N.W., Simoncsits A., Susic S., Rahman K., Marusic L., and Chen J. Human DNA helicase II: a novel DNA unwinding enzyme identified as the Ku autoantigen. EMBO J. 13 (1994) 4991-5001
58. Cao Q.P., Pitt S., Leszyk J., and Baril E.F. DNA-dependent ATPase from HeLa cells is related to human Ku autoantigen. Biochemistry 33 (1994) 8548-8557
59. Messier H., Fuller T., Mangal S., Brickner H., Igarashi S., Gaikwad J., Fotedar R., and Fotedar A. p70 lupus autoantigen binds the enhancer of the T-cell receptor beta-chain gene. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 2685-2689
60. Shieh B., Schultz J., Guinness M., and Lacy J. Regulation of the human IgE receptor (Fc epsilonRII/CD23) by Epstein-Barr virus (EBV): Ku autoantigen binds specifically to an EBV-responsive enhancer of CD23. Int. Immunol. 9 (1997) 1885-1895
61. Kurimasa A., Ouyang H., Dong L.J., Wang S., Li X., Cordon-Cardo C., Chen D.J., and Li G.C. Catalytic subunit of DNA-dependent protein kinase: impact on lymphocyte development and tumorigenesis. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 1403-1408
62. Nussenzweig A., Chen C., da C.S., Sanchez V.M., Sokol K., Nussenzweig M.C., and Li G.C. Requirement for Ku80 in growth and immunoglobulin V(D)J recombination. Nature 382 (1996) 551-555
63. Li G., Nelsen C., and Hendrickson E.A. Ku86 is essential in human somatic cells. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 832-837
64. Nussenzweig A., Sokol K., Burgman P., Li L., and Li G.C. Hypersensitivity of Ku80-deficient cell lines and mice to DNA damage: the effects of ionizing radiation on growth, survival, and development. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 13588-13593
65. Cai Q.Q., Plet A., Imbert J., Lafage-Pochitaloff M., Cerdan C., and Blanchard J.M. Chromosomal location and expression of the genes coding for Ku p70 and p80 in human cell lines and normal tissues. Cytogenet. Cell Genet. 65 (1994) 221-227
66. Casellas R., Nussenzweig A., Wuerffel R., Pelanda R., Reichlin A., Suh H., Qin X.F., Besmer E., Kenter A., Rajewsky K., and Nussenzweig M.C. Ku80 is required for immunoglobulin isotype switching. EMBO J. 17 (1998) 2404-2411
67. Manis J.P., Gu Y., Lansford R., Sonoda E., Ferrini R., Davidson L., Rajewsky K., and Alt F.W. Ku70 is required for late B cell development and immunoglobulin heavy chain class switching. J. Exp. Med. 187 (1998) 2081-2089
68. Ouyang H., Nussenzweig A., Kurimasa A., Soares V.C., Li X., Cordon-Cardo C., Li W., Cheong N., Nussenzweig M., Iliakis G., Chen D.J., and Li G.C. Ku70 is required for DNA repair but not for T cell antigen receptor gene recombination In vivo. J. Exp. Med. 186 (1997) 921-929
69. Danska J.S., Pflumio F., Williams C.J., Huner O., Dick J.E., and Guidos C.J. Rescue of T cell-specific V(D)J recombination in SCID mice by DNA-damaging agents. Science 266 (1994) 450-455
70. Strasser A., Harris A.W., Corcoran L.M., and Cory S. Bcl-2 expression promotes B- but not T-lymphoid development in scid mice. Nature 368 (1994) 457-460
71. Muller C., Dusseau C., Calsou P., and Salles B. Human normal peripheral blood B-lymphocytes are deficient in DNA-dependent protein kinase activity due to the expression of a variant form of the Ku86 protein. Oncogene 16 (1998) 1553-1560
72. Han Z., Johnston C., Reeves W.H., Carter T., Wyche J.H., and Hendrickson E.A. Characterization of a Ku86 variant protein that results in altered DNA binding and diminished DNA-dependent protein kinase activity. J. Biol. Chem. 271 (1996) 14098-14104
73. Tai Y.T., Teoh G., Lin B., Davies F.E., Chauhan D., Treon S.P., Raje N., Hideshima T., Shima Y., Podar K., and Anderson K.C. Ku86 variant expression and function in multiple myeloma cells is associated with increased sensitivity to DNA damage. J. Immunol. 165 (2000) 6347-6355
74. Jeng Y.W., Chao H.C., Chiu C.F., and Chou W.G. Senescent human fibroblasts have elevated Ku86 proteolytic cleavage activity. Mutat. Res. 435 (1999) 225-232
75. Kato M., Iida S., Komatsu H., and Ueda R. Lack of ku80 alteration in multiple myeloma. Jpn. J. Cancer Res. 93 (2002) 359-362
76. Gullo C., Feng G., Cow G., and Teoh G. The biochemical characterization of three forms of the Ku86 protein in multiple myeloma cell lines. Blood 106 11 (2005) 954a (Abstract)
77. Lanuszewska J., and Widlak P. The truncation of Ku86 in human lymphocytes. Cancer Lett. 205 (2004) 197-205
78. Sallmyr A., Henriksson G., Fukushima S., and Bredberg A. Ku protein in human T and B lymphocytes: full length functional form and signs of degradation. Biochim. Biophys. Acta 1538 (2001) 305-312
79. Sallmyr A., Du L., and Bredberg A. An inducible Ku86-degrading serine protease in human cells. Biochim. Biophys. Acta 1593 (2002) 57-68
80. Khanna K.K., and Jackson S.P. DNA double-strand breaks: signaling, repair and the cancer connection. Nat. Genet. 27 (2001) 247-254
81. K.W. Kinzler, B.Vogelstein, Cancer-susceptibility genes. Gatekeepers and caretakers, Nature, 386, (1997) 761-763.
82. Difilippantonio M.J., Zhu J., Chen H.T., Meffre E., Nussenzweig M.C., Max E.E., Ried T., and Nussenzweig A. DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation. Nature 404 (2000) 510-514
83. Gao Y., Ferguson D.O., Xie W., Manis J.P., Sekiguchi J., Frank K.M., Chaudhuri J., Horner J., DePinho R.A., and Alt F.W. Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development. Nature 404 (2000) 897-900
84. Tong W.M., Cortes U., Hande M.P., Ohgaki H., Cavalli L.R., Lansdorp P.M., Haddad B.R., and Wang Z.Q. Synergistic role of Ku80 and poly(ADP-ribose) polymerase in suppressing chromosomal aberrations and liver cancer formation. Cancer Res. 62 (2002) 6990-6996
85. Lindahl T., Satoh M.S., Poirier G.G., and Klungland A. Post-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks. Trends Biochem. Sci. 20 (1995) 405-411
86. Herceg Z., and Wang Z.Q. Functions of poly(ADP-ribose) polymerase (PARP) in DNA repair, genomic integrity and cell death. Mutat. Res. 477 (2001) 97-110
87. Tong W.M., Hande M.P., Lansdorp P.M., and Wang Z.Q. DNA strand break-sensing molecule poly(ADP-Ribose) polymerase cooperates with p53 in telomere function, chromosome stability, and tumor suppression. Mol. Cell. Biol. 21 (2001) 4046-4054
88. Lim J.W., Kim H., and Kim K.H. Expression of Ku70 and Ku80 mediated by NF-kappa B and cyclooxygenase-2 is related to proliferation of human gastric cancer cells. J. Biol. Chem. 277 (2002) 46093-46100
89. Lim J.W., Kim H., and Kim K.H. Nuclear factor-kappaB regulates cyclooxygenase-2 expression and cell proliferation in human gastric cancer cells. Lab. Invest. 81 (2001) 349-360
90. Raz A. Is inhibition of cyclooxygenase required for the anti-tumorigenic effects of nonsteroidal, anti-inflammatory drugs (NSAIDs)? In vitro versus in vivo results and the relevance for the prevention and treatment of cancer. Biochem. Pharmacol. 63 (2002) 343-347
91. Sheng H., Shao J., Morrow J.D., Beauchamp R.D., and DuBois R.N. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res. 58 (1998) 362-366
92. Klein A., Miera O., Bauer O., Golfier S., and Schriever F. Chemosensitivity of B cell chronic lymphocytic leukemia and correlated expression of proteins regulating apoptosis, cell cycle and DNA repair. Leukemia 14 (2000) 40-46
93. Pucci S., Mazzarelli P., Rabitti C., Giai M., Gallucci M., Flammia G., Alcini A., Altomare V., and Fazio V.M. Tumor specific modulation of KU70/80 DNA binding activity in breast and bladder human tumor biopsies. Oncogene 20 (2001) 739-747
94. Kashishian A., Douangpanya H., Clark D., Schlachter S.T., Eary C.T., Schiro J.G., Huang H., Burgess L.E., Kesicki E.A., and Halbrook J. DNA-dependent protein kinase inhibitors as drug candidates for the treatment of cancer. Mol. Cancer Ther. 2 (2003) 1257-1264
95. Frit P., Canitrot Y., Muller C., Foray N., Calsou P., Marangoni E., Bourhis J., and Salles B. Cross-resistance to ionizing radiation in a murine leukemic cell line resistant to cis-dichlorodiammineplatinum(II): role of Ku autoantigen. Mol. Pharmacol. 56 (1999) 141-146
96. Kim S.H., Kim D., Han J.S., Jeong C.S., Chung B.S., Kang C.D., and Li G.C. Ku autoantigen affects the susceptibility to anticancer drugs. Cancer Res. 59 (1999) 4012-4017
97. Gabai V.L., Meriin A.B., Mosser D.D., Caron A.W., Rits S., Shifrin V.I., and Sherman M.Y. Hsp70 prevents activation of stress kinases. A novel pathway of cellular thermotolerance. J. Biol. Chem. 272 (1997) 18033-18037
98. Samali A., and Cotter T.G. Heat shock proteins increase resistance to apoptosis. Exp. Cell Res. 223 (1996) 163-170
99. Tai Y.T., Podar K., Kraeft S.K., Wang F., Young G., Lin B., Gupta D., Chen L.B., and Anderson K.C. Translocation of Ku86/Ku70 to the multiple myeloma cell membrane: functional implications. Exp. Hematol. 30 (2002) 212-220
100. Lynch E.M., Moreland R.B., Ginis I., Perrine S.P., and Faller D.V. Hypoxia-activated ligand HAL-1/13 is lupus autoantigen Ku80 and mediates lymphoid cell adhesion in vitro. Am. J. Physiol.: Cell Physiol. 280 (2001) C897-C911
101. Li G.C., He F., Shao X., Urano M., Shen L., Kim D., Borrelli M., Leibel S.A., Gutin P.H., and Ling C.C. Adenovirus-mediated heat-activated antisense Ku70 expression radiosensitizes tumor cells in vitro and in vivo. Cancer Res. 63 (2003) 3268-3274